MARKET

MBRX

MBRX

Moleculin
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.270
0.000
0.00%
Opening 10:02 09/18 EDT
OPEN
1.270
PREV CLOSE
1.270
HIGH
1.280
LOW
1.259
VOLUME
38.59K
TURNOVER
--
52 WEEK HIGH
3.150
52 WEEK LOW
0.7772
MARKET CAP
57.40M
P/E (TTM)
-3.6812
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of MBRX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

MBRX News

  • 22 Healthcare Stocks Moving In Monday's Pre-Market Session
  • Benzinga.2d ago
  • Moleculin Announces its Sponsored Research at MD Anderson Cancer Center Has Resulted in the Filing of Patent Protection for New Discovery
  • PR Newswire.2d ago
  • 22 Healthcare Stocks Moving In Tuesday's Pre-Market Session
  • Benzinga.08/20 12:32
  • 32 Stocks Moving in Tuesday's Pre-Market Session
  • Benzinga.08/20 11:49

More

Industry

Pharmaceuticals
-0.15%
Pharmaceuticals & Medical Research
-0.27%

Hot Stocks

Name
Price
%Change

About MBRX

Moleculin Biotech, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on the development of anti-cancer drug candidates. Its lead drug candidate is liposomal Annamycin, which it refers to as Annamycin, an anthracycline intended for the treatment of relapsed or refractory acute myeloid leukemia (AML). Annamycin is a Phase II clinical-stage anthracycline and liposome formulated anthracycline that has been designed to eliminate cardiotoxicity and avoid the multidrug resistance mechanisms. It has over two other drug development projects in progress, one involving a portfolio of small molecules, which it refers to as the WP1066 Portfolio, focused on the modulation of key oncogenic transcription factors involved in the progression of cancer, and the WP1122 Portfolio, a suite of molecules targeting the metabolic processes involved in cancer in general, and glioblastoma. As of April 3, 2017, it had not generated any revenue from its operations.
More

Webull offers Moleculin Biotech Inc (MBRX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.